After 19 years of survivorship, one cancer survivor reflects on life's changing seasons, managing scan anxiety and finding support beyond treatment.
|Podcasts|July 5, 2018
Moving Mountains
Author(s)Kristie L. Kahl
We spoke with two members of the Moving Mountains for Multiple Myeloma team.
Advertisement
Moving Mountains for Multiple Myeloma (MM4MM) is a collaboration to raise awareness and funds for myeloma research where patients, caregivers, doctors, nurses and loved ones take on challenging mountain climbs throughout the year. On this year’s domestic hike, a team of 20 explored the Havasu Falls region of the Grand Canyon.
In this week’s episode, we spoke with two climbers: Jamie Tinschert, who received a multiple myeloma diagnosis in June 2012, and Chris Seal, a marketing director for an oncology brand at Amgen — who also sponsored the Havasu Falls climb – about their experience and why the MM4MM treks are key to raising awareness for multiple myeloma.
Advertisement
Related to this article
Psychiatrist Dr. Yesne Alici of Memorial Sloan Kettering Cancer Center answers questions about family relationships during cancer, from asking for help to talking with children and friends.
Among more than 12,000 cancer survivors 65 and older, those who stayed physically active after diagnosis tended to have lower health care costs, an American Cancer Society study published Oct. 21, 2026, in CANCER found.
The FDA grants traditional approval to Keytruda and Keytruda Qlex for TMB-H solid tumors, updating the threshold to at least 13 mutations per megabase.
Martha Carlson reflects on her 11 years with metastatic breast cancer and explores how resilience, purpose and the stories we tell ourselves shape the cancer experience.
A study found that 1 in 9 older cancer survivors developed a second cancer, highlighting why routine screening remains important beyond five years.
After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
Learn why hepatitis B can reactivate during cancer treatment, which therapies increase the risk and how antiviral medicines can help protect liver health.
Advertisement
Advertisement
Trending on CURE
1
FDA Grants Traditional Approval to Keytruda for TMB-H Solid Tumors
2
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
3
Psychiatrist Answers Questions About Family and Relationships During Cancer
4
Why Cancer Screening Remains Important for Long-Term Cancer Survivors
5